DIAMYD MEDICAL AB Inactive Instrument
Diamyd Medical AB Stock Nasdaq Stockholm
Equities
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - SEK | - |
|
| Sales 2018 | - | Sales 2019 | - | Capitalization | 1.03B 11.3B |
|---|---|---|---|---|---|
| Net income 2018 | 25M 275M | Net income 2019 | 77M 847M | EV / Sales 2018 | - |
| Net cash position 2018 | 253M 2.78B | Net cash position 2019 | 83.08M 914M | EV / Sales 2019 | - |
| P/E ratio 2018 |
28.3
x | P/E ratio 2019 |
13.3
x | Employees | - |
| Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 68.13% |
More Fundamentals
* Assessed data
More news
Mertiva AB, formerly Diamyd Medical AB, is a Sweden-based company active within the healthcare sector. As of August 31, 2013, the Company owned 8% shares of the United-States based Protein Sciences Corporation, as well as 19% shares of Mercodia AB. The Company changed its name in May 2013. Additionally, its subsidiary, Diamyd Therapeutics, was spun off and changed its name to Diamyd Medical.
| 1st Jan change | Capi. | |
|---|---|---|
| -1.82% | 41.35B | |
| +44.25% | 40.38B | |
| +2.56% | 39.05B | |
| -12.11% | 26.67B | |
| +3.09% | 24.07B | |
| -24.16% | 18.36B | |
| +22.12% | 11.6B | |
| -3.74% | 11.68B | |
| +7.75% | 11.15B |
